The company's object is the development and approval of pharmaceutical preparations as well as the trade in pharmaceutical preparations and care products of all kinds. The company is domiciled in Mannheim and is a 100% subsidiary of Sinclair Pharma Holdings Limited, London; the annual financial statements are included in the consolidated financial statements of Sinclair Pharma Limited. The fully paid share capital amounts to EUR 25,000.00. In the 2023 financial year the company employed an average of 13 employees and there is a hard comfort letter from the parent company valid until July 2025.
Die Entwicklung und die Zulassung von pharmazeutischen Präparaten sowie der Handel mit pharmazeutischen Präparaten und Pflegemitteln jeder Art.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Mannheim Local Court, HRB 726234 (as of 30 October 2026)
| Name | Type | City |
|---|---|---|
| Qifei Xing | Geschäftsführer(in) | Chester |
Source: German Commercial Register (Handelsregister) Mannheim Local Court, HRB 726234 (as of 30 October 2026)
| Date | Event Type | Event |
|---|---|---|
| 16.02.2026 | Registered Seat Change | Neue |
| 16.02.2026 | Business Address Change | Martin-Behaim-Straße 12, 63263 NeuIsenburg |
| 21.01.2022 | Registered Seat Change | Mannheim |
| Date | Type | Change | Total Capital |
|---|---|---|---|
| 10.11.2016 | Share Capital Set | — | 25.000 € |
Source: German Commercial Register (Handelsregister) Mannheim Local Court, HRB 726234 (as of 30 October 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2024 | €2,762,036 | €96,621 | €3,747,659 | 13 |
| 2023 | €3,046,586 | €141,186 | €3,153,873 | 13 |
| 2022 | €2,385,521 | €106,313 | €3,241,468 | 13 |
| 2021 | €2,523,810 | €110,227 | €2,015,714 | 11 |
| 2020 | small company1 | — | €1,427,617 | 11 |
| 2019 | small company1 | — | €1,305,244 | 11 |
| 2018 | small company1 | — | €1,192,073 | 9 |
| 2017 | small company1 | — | €2,546,858 | 11 |
| 2016 | small company1 | — | €2,388,535 | 9 |
| 2015 | small company1 | -€171,503 | €3,824,938 | — |
1 Small companies are not required to publish a profit-and-loss statement (§ 326 (1) HGB). The figure shown is the statutory ceiling under § 267 HGB where the balance-sheet total makes it binding — a company may exceed at most one of the three size criteria.
Sign in to download data
Source: German Commercial Register (Handelsregister) Mannheim Local Court, HRB 726234 (as of 30 October 2026)
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €1,354,364 | 99.5% |
| Depreciation | €6,952 | 0.5% |
